NOVACYT SIGNS STRATEGIC ALLIANCE WITH CEPHEID FOR HPV DIAGNOSTICS IN LATIN AMERICA

strategic-alliance-agreement-with-cepheid Paris, France and Cambridge, UK – 4th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance with Cepheid Inc., a leading international molecular diagnostics company, to introduce a complete Human Papillomavirus (HPV) diagnostic system into Latin America.

Visit Page